跳至主要内容
分组视图 1739 条记录 · 页 4/35

化妆品禁用物质 — 附件 II

附件 II 列出了禁止作为化妆品成分有意添加的物质。第 17 条另行规定了在良好生产规范和第 3 条安全要求下技术上不可避免的非有意微量存在的情形。本页包含 1739 条记录。

筛选此附件

本附件的作用方式

Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.

  • 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
  • Prohibition covers intentional addition; there is no permitted concentration.
  • Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
  • Absence from Annex II is not permission — most substances appear in no annex at all.

Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.

The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.

Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.

The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.

核对依据

附件 II 记录

1739 共
本列表中的记录,共 1739 条
条目物质CAS最大浓度标记
151Dinitrophenol isomersCAS 51-28-5 / 329-71-5 / 573-56-8 / 25550-58-7 51-28-5 / 329-71-5 / 573-56-8 / 25550-58-7 —
152Inproquone (INN)CAS 436-40-8 436-40-8 —
153Dimevamide (INN) and its saltsCAS 60-46-8 60-46-8 —
154Diphenylpyraline (INN) and its saltsCAS 147-20-6 147-20-6 —
155Sulfinpyrazone (INN)CAS 57-96-5 57-96-5 —
156N-(3-Carbamoyl-3,3-diphenylpropyl)-N,N-diisopropylmethylammonium salts, e.g. isopropamide iodide (INN)CAS 71-81-8 71-81-8 —
157Benactyzine (INN)CAS 302-40-9 302-40-9 —
158Benzatropine (INN) and its saltsCAS 86-13-5 86-13-5 —
159Cyclizine (INN) and its saltsCAS 82-92-8 82-92-8 —
1605,5-Diphenyl-4-imidazolidone (Doxenitoin (INN))CAS 3254-93-1 3254-93-1 —
161Probenecid (INN)CAS 57-66-9 57-66-9 —
162Disulfiram (INN)thiram (ISO) (INN)CAS 97-77-8 / 137-26-8 97-77-8 / 137-26-8 —
163Emetine, its salts and derivativesCAS 483-18-1 483-18-1 —
164Ephedrine and its saltsCAS 299-42-3 299-42-3 —
165Oxanamide (INN) and its derivativesCAS 126-93-2 126-93-2 —
166Eserine or physostigmine and its saltsCAS 57-47-6 57-47-6 —
1674-Aminobenzoic acid and its esters, with the free amino groupCAS 150-13-0 150-13-0 —
168Choline salts and their esters e.g. choline chloride (INN)CAS 67-48-1 67-48-1 —
169Caramiphen (INN) and its saltsCAS 77-22-5 77-22-5 —
170Diethyl 4-nitrophenyl phosphate (Paraoxon - ISO)CAS 311-45-5 311-45-5 —
171Metethoheptazine (INN) and its saltsCAS 509-84-2 509-84-2 —
172Oxpheneridine (INN) and its saltsCAS 546-32-7 546-32-7 —
173Ethoheptazine (INN) and its saltsCAS 77-15-6 77-15-6 —
174Metheptazine (INN) and its saltsCAS 469-78-3 469-78-3 —
175Methylphenidate (INN) and its saltsCAS 113-45-1 113-45-1 —
176Doxylamine (INN) and its saltsCAS 469-21-6 469-21-6 —
177Tolboxane (INN)CAS 2430-46-8 2430-46-8 —
1784-Benzyloxyphenol and 4-ethoxyphenolCAS 103-16-2 / 622-62-8 103-16-2 / 622-62-8 —
179Parethoxycaine (INN) and its saltsCAS 94-23-5 94-23-5 —
180Fenozolone (INN)CAS 15302-16-6 15302-16-6 —
181Glutethimide (INN) and its saltsCAS 77-21-4 77-21-4 —
182Ethylene oxideCAS 75-21-8 75-21-8 —CMR
183Bemegride (INN) and its saltsCAS 64-65-3 64-65-3 —
184Valnoctamide (INN)CAS 4171-13-5 4171-13-5 —
185Haloperidol (INN)CAS 52-86-8 52-86-8 —
186Paramethasone (INN)CAS 53-33-8 53-33-8 —
187Fluanisone (INN)CAS 1480-19-9 1480-19-9 —
188Trifluperidol (INN)CAS 749-13-3 749-13-3 —
189Fluoresone (INN)CAS 2924-67-6 2924-67-6 —
190Fluorouracil (INN)CAS 51-21-8 51-21-8 —
191Hydrofluoric acid, its normal salts, its complexes and hydrofluorides with exception of those given in Annex IIICAS 7664-39-3 7664-39-3 —
192Furfuryltrimethyl ammonium salts, e.g. furtrethonium iodide (INN)CAS 541-64-0 541-64-0 —
193Galantamine (INN)CAS 357-70-0 357-70-0 —
194Progestogens——
1951,2,3,4,5,6-Hexachlorocyclohexane (BHC-ISO)CAS 58-89-9 / - 58-89-9 / - —
196(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene (endrin - ISO)CAS 72-20-8 72-20-8 —
197HexachloroethaneCAS 67-72-1 67-72-1 —
198(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene (Isodrin-ISO)CAS 465-73-6 465-73-6 —
199Hydrastine, hydrastinine and their saltsCAS 118-08-1 / 6592-85-4 118-08-1 / 6592-85-4 —
200Hydrazides and their salts e.g. Isoniazid (INN)CAS 54-85-3 54-85-3 —

如何使用此分组视图

附件 II 包含化妆品禁用物质。当您想按名称、标识符和关联条目页面快速浏览 1739 条禁用物质记录时,请使用此分组视图。

当您需要完整的法律措辞、浓度逻辑、警示语或相关标识符的交叉链接时,请打开单条记录。